Cargando…
A non-genetic switch triggers alternative telomere lengthening and cellular immortalization in ATRX deficient cells
Alternative Lengthening of Telomeres (ALT) is an aberrant DNA recombination pathway which grants replicative immortality to approximately 10% of all cancers. Despite this high prevalence of ALT in cancer, the mechanism and genetics by which cells activate this pathway remain incompletely understood....
Autores principales: | Turkalo, Timothy K., Maffia, Antonio, Schabort, Johannes J., Regalado, Samuel G., Bhakta, Mital, Blanchette, Marco, Spierings, Diana C. J., Lansdorp, Peter M., Hockemeyer, Dirk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941109/ https://www.ncbi.nlm.nih.gov/pubmed/36805596 http://dx.doi.org/10.1038/s41467-023-36294-6 |
Ejemplares similares
-
ATRX represses alternative lengthening of telomeres
por: Napier, Christine E., et al.
Publicado: (2015) -
The Role of ATRX in the Alternative Lengthening of Telomeres (ALT) Phenotype
por: Amorim, João P., et al.
Publicado: (2016) -
Alternative lengthening of telomeres is not synonymous with mutations in ATRX/DAXX
por: de Nonneville, Alexandre, et al.
Publicado: (2021) -
Suppression of the alternative lengthening of telomere pathway by the chromatin remodelling factor ATRX
por: Clynes, David, et al.
Publicado: (2015) -
Formal reply to “Alternative lengthening of telomeres is not synonymous with mutations in ATRX/DAXX”
por: Feuerbach, Lars
Publicado: (2021)